China Universal Asset Management Company’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$142K Sell
7,017
-1,034
-13% -$20.9K 0.01% 386
2026
Q1
$158K Buy
8,051
+563
+8% +$13.8K 0.01% 369
2025
Q4
$201K Sell
7,488
-662
-8% -$17.1K 0.02% 343
2025
Q3
$217K Sell
8,150
-1,318
-14% -$34K 0.02% 328
2025
Q2
$217K Sell
9,468
-176
-2% -$4.37K 0.02% 305
2025
Q1
$280K Sell
9,644
-551
-5% -$17.6K 0.03% 289
2024
Q4
$379K Buy
10,195
+833
+9% +$38.1K 0.04% 275
2024
Q3
$454K Buy
9,362
+3,617
+63% +$159K 0.05% 235
2024
Q2
$230K Sell
5,745
-3,501
-38% -$145K 0.03% 221
2024
Q1
$406K Buy
9,246
+3,704
+67% +$191K 0.05% 203
2023
Q4
$343K Buy
5,542
+4,281
+339% +$225K 0.07% 167
2023
Q3
$58K Buy
1,261
+628
+99% +$34.3K 0.02% 226
2023
Q2
$36.4K Sell
633
-22
-3% -$975 0.01% 224
2023
Q1
$24.6K Buy
655
+164
+33% +$5.38K 0.01% 201
2022
Q4
$13.8K Buy
491
+32
+7% +$929 0.01% 203
2022
Q3
$13K Buy
+459
New +$15K 0.01% 182

Other funds holding AMPH

China Universal Asset Management Company's AMPH Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Amphastar Pharmaceuticals (AMPH) stake by 13% in Q2 2026, selling an estimated $20.9K and leaving 7,017 shares worth $142K. The position accounts for 0.01% of the portfolio, ranked #386.

China Universal Asset Management Company first reported a position in AMPH in Q3 2022 and has held it in 16 quarters since. The position peaked at $454K in Q3 2024. 122 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.

  • China Universal Asset Management Company held 7,017 shares of Amphastar Pharmaceuticals worth $142K as of Q2 2026.
  • China Universal Asset Management Company sold 1,034 Amphastar Pharmaceuticals shares in Q2 2026, an estimated $20.9K.
  • Amphastar Pharmaceuticals made up 0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #386 holding.
  • China Universal Asset Management Company first reported a position in Amphastar Pharmaceuticals in Q3 2022 and has held it in 16 quarters since.
  • China Universal Asset Management Company's Amphastar Pharmaceuticals position peaked at $454K in Q3 2024.
  • 122 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.